Agenda


Thursday, Feb. 9, 2023

12:00 p.m. – 05:00 p.m. – Registration

Pre-Symposium Workshop: Breast Cancer Risk Assessment
Moderator: Freya Schnabel, MD

01:00 p.m. – 01:30p.m. The Problem of Risk Assessment and Surveillance in High Risk BRCA Negative Patients
Freya Schnabel, MD

01:30 p.m. – 02:00p.m. Modifiable Risk Factors
Weizhou Zhang, MS, PhD

02:00 p.m. – 02:30p.m. Increasing Access with New Technologies
Banu Arun, MD

02:30 p.m. – 03:00p.m. BREAK

03:00 p.m. – 03:30p.m. Atypical Ductal Hyperplasia/Lobular Carcinoma in situ Update Including Genomics
Shahla Masood, MD

03:30 p.m. – 04:00p.m. Polygenic Risk Factors
Pat Whitworth, MD

04:00 p.m. – 04:30p.m. Genetics in Action: Panel on PARP Inhibitors
Claudine Isaacs, MD

04:30 p.m. – 05:00p.m. Panel Discussion
Banu Arun, MD; Claudine Isaacs, MD; Shahla Masood, MD; Freya Schnabel, MD; Pat Whitworth, MD and Weizhou Zhang, MS, PhD

Friday, Feb. 10, 2023

07:00 a.m. – 08:00 a.m. – Registration, Breakfast and Exhibits

07:55 a.m. – 08:00 a.m. Welcoming Remarks and Introduction of Keynote Speaker
Shahla Masood, MD

08:00 a.m. – 09:00 a.m. Keynote Lecture – Changing Landscape in the Regional Nodal Management of Breast Cancer
Bruce Haffty, MD

Session I: The Status of Breast Cancer Across the Globe
Moderator: Pat Whitworth, MD

09:00 a.m. – 09:30 a.m. Addressing the Continuous Dilemma of Breast Cancer Disparities Among Medically Underserved Population. A Call to Action
Shahla Masood, MD

09:30 a.m. – 10:00 a.m. Global Disparities in Genetic Cancer Risk Assessment: Access, Biology or Both
Pat Whitworth, MD

10:00 a.m. – 10:30 a.m. BREAK and EXHIBITS

10:30 a.m. – 11:00 a.m. Breast Cancer Screening Among the Elderly
Dejana Braithwaite, PhD, MSc

11:00 a.m. – 11:30 a.m. BESPOKE ctDNA Monitoring for Breast Cancer Treatment and Surveillance
Pat Whitworth, MD

11:30 a.m. – 12:00 p.m. Panel Discussion
Dejana Braithwaite, PhD, MSc; Bruce Haffty, MD; Shahla Masood, MD; and Pat Whitworth, MD

12:00 p.m. – 1:00 p.m. LUNCH AND EXHIBITS

Session II: Breast Cancer Screening and Diagnoses
Moderator: Freya Schnabel, MD

01:00 p.m. – 01:30 p.m. An Update on Breast Cancer Genetics
Banu Arun, MD

01:30 p.m. – 02:00 p.m. Management of High Risk Breast Cancer Patients
Freya Schnabel, MD

02:00 p.m. – 02:30 p.m. BREAK and EXHIBITS

02:30 p.m. – 03:15 p.m. Abbreviated Breast MRI for Screening Women with Dense Breast
Christopher E Comstock, MD

03:15 p.m. – 03:45 p.m. Current Status of Breast Ultrasound Screening in Women with Dense Breast
Reni Butler, MD

03:45 p.m. – 04:30 p.m. Contrast Enhanced Spectral Mammography: Technique and Applications
Christopher E. Comstock, MD

04:30 p.m. – 05:00 p.m. Panel Discussion:
Banu Arun, MD; Reni Butler, MD; Christopher E. Comstock, MD; and Freya Schnabel, MD

Saturday, Feb. 11, 2023

07:00 a.m. – 08:00 a.m. – Registration, Breakfast and Exhibits

Session III: New Concepts in Surgical Management
Moderator: Terry Mamounas, MD

08:00 a.m. – 08:30 a.m. Is it Time to Abandon the Term of Low Grade Ductal Carcinoma in situ and Replace it with “Borderline Breast Lesions” in Breast Core Needle Biopsy?
Shahla Masood, MD

08:30 a.m. – 09:00 a.m. Update on Surgical Management of Ductal Carcinoma in situ
Shelley Hwang, MD, MPH

09:00 a.m. – 09:30 a.m. Radiation Therapy for Ductal Carcinoma in situ: Is it Necessary for Low Grade Ductal Carcinoma in situ?
Bruce Haffty, MD

09:30 a.m. – 10:00 a.m. BREAK AND EXHIBITS

10:00 a.m. – 10:30 a.m. The Dilemma of Positive Margins
Shelley Hwang, MD, MPH

10:30 a.m. – 11:00 a.m. Surgical Techniques to Reduce Morbidity from Axillary Surgery
Terry Mamounas, MD

11:00 a.m. – 11:30 a.m. Oncoplastic Breast Conservation for Just About all Patients
Melvin J. Silverstein, MD

11:30 a.m. – 12:00 p.m. Panel Discussion:
Bruce Haffty, MD; Shelley Hwang, MD, MPH; Terry Mamounas, MD; Shahla Masood, MD and Melvin J. Silverstein, MD

12:00 p.m. – 1:00 p.m. LUNCH AND EXHIBITS

Session IV: Advances in Breast Cancer Therapy
Moderator: Elizabeth A. Mittendorf, MD, PhD

01:00 p.m. – 01:30 p.m. Beyond Breast Reconstruction: Breast Regeneration
John D. Murray, MD

01:30 p.m. – 02:00 p.m. Axillary Management after Neoadjuvant Chemotherapy
Terry Mamounas, MD

02:00 p.m. – 02:30 p.m. MBC: Role of Immunotherapy and Updates on CDK4/6i
Claudine Isaacs, MD

02:30 p.m. – 03:00 p.m. Neoadjuvant Immunotherapy
Elizabeth A. Mittendorf, MD, PhD

03:00 p.m. – 03:30 p.m. BREAK and EXHIBITS

03:30 p.m. – 04:00 p.m. ER+ Early Stage Breast Cancer: Who Needs Chemotherapy and Role of CDK4/6i
Claudine Isaacs, MD

04:00 p.m. – 04:30 p.m. Antibody-Drug Conjugates for Breast Cancer: What is New?
Banu Arun, MD

04:30 p.m. – 05:00 p.m. Panel Discussion:
Banu Arun, MD; Claudine Isaacs, MD; Terry Mamounas, MD; Elizabeth A. Mittendorf, MD, PhD; and John D. Murray, MD

Sunday, Feb. 12, 2023

7:00 a.m. – 8:00 a.m. – Registration, Breakfast and Exhibits

Session V: Contemporary Issues in Breast Cancer
Moderator: Shahla Masood, MD

08:00 a.m. – 08:30 a.m. An Overview of Breast Cancer Biomarker Testing
Gary Tozbikian, MD

08:30 a.m. – 09:30 a.m. Breast Tumor Conference
Freya Schnabel, MD

09:30 a.m. – 10:00 a.m. An update on Breast Cancer with Low HER2 Expression
Gary Tozbikian, MD

10:00 a.m. – 10:30 a.m. Implant Based Breast Reconstruction: Where are We Now?
John D. Murray, MD

10:30 a.m. – 11:00 a.m. Breast Cancer Survivorship
Shahla Masood, MD

11:00 a.m. – 11:30 a.m. Panel Discussion:
Shahla Masood, MD; John D. Murray, MD; Freya Schnabel, MD and Gary Tozbikian, MD


11:30 a.m. – 12:00 p.m. Closing Remarks
Shahla Masood, MD